Use of markers of dyslipidemia to identify overweight youth with insulin resistance

Pediatric Diabetes

Volumn 7, Issue 5, 2006, Pages 260-266

  Hannon, Tamara S ^a,b   Bacha, Fida ^a,b   Lee, So Jung ^a,b   Janosky, Janine ^a   Arslanian, Silva A ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

Euglycemic clamp; High density lipoprotein cholesterol; Hyperinsulinemic; Insulin sensitivity; Obesity; Triglycerides

Indexed keywords

ADIPONECTIN; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN; INSULIN; LIPID; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADOLESCENT; ARTICLE; BODY FAT; BODY MASS; CAUCASIAN; CLINICAL ARTICLE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORRELATION ANALYSIS; DIASTOLIC BLOOD PRESSURE; DIET RESTRICTION; DISEASE ASSOCIATION; DISEASE MARKER; DISEASE SEVERITY; DUAL ENERGY X RAY ABSORPTIOMETRY; DYSLIPIDEMIA; FEMALE; GLUCOSE CLAMP TECHNIQUE; HUMAN; HYPERINSULINEMIA; INSULIN RESISTANCE; INSULIN SENSITIVITY; MALE; MEDICAL RESEARCH; METABOLIC SYNDROME X; OBESITY; PREDICTION; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE;

ABDOMINAL FAT; ABSORPTIOMETRY, PHOTON; ADIPOSE TISSUE; ADOLESCENT; BIOLOGICAL MARKERS; DENSITOMETRY, X-RAY; DYSLIPIDEMIAS; FEMALE; GLUCOSE CLAMP TECHNIQUE; HUMANS; INSULIN; INSULIN RESISTANCE; LIPOPROTEINS, HDL; MALE; OVERWEIGHT; RETROSPECTIVE STUDIES; ROC CURVE; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED; TRIGLYCERIDES;

EID: 33750119816     PISSN: 1399543X     EISSN: 13995448     Source Type: Journal    
DOI: 10.1111/j.1399-5448.2006.00199.x     Document Type: Article

References (29)

1. Bobo N, Evert A, Gallivan J et al. An update on type 2 diabetes in youth from the National Diabetes Education Program. Pediatrics 2004: 114: 259-263.
2. Steinberger J, Daniels SR. Obesity, insulin resistance, diabetes, and cardiovascular risk in children: An American Heart Association scientific statement from the Atherosclerosis, Hypertension, and Obesity in the Young Committee (Council on Cardiovascular Disease in the Young) and the Diabetes Committee (Council on Nutrition, Physical Activity, and Metabolism). Circulation 2003: 107: 1448-1453.
3. Gidding SS, Nehgme R, Heise C, Muscar C, Linton A, Hassink S. Severe obesity associated with cardiovascular deconditioning, high prevalence of cardiovascular risk factors, diabetes mellitus/hyperinsulinemia, and respiratory compromise. J Pediatr 2004: 144: 766-769.
4. Arslanian S, Suprasongsin C. Insulin sensitivity, lipids, and body composition in childhood: Is "syndrome X"present? J Clin Endocrinol Metab 1996: 81: 1058-1062.
5. Cnop M, Landchild MJ, Vidal J et al. The concurrent accumulation of intra-abdominal and subcutaneous fat explains the association between insulin resistance and plasma leptin concentrations: Distinct metabolic effects of two fat compartments. Diabetes 2002: 51: 1005-1015.
6. Mc Laughlin T, Allison G, Abbasi F, Lamendola C, Reaven G. Prevalence of insulin resistance and associated cardiovascular disease risk factors among normal weight, overweight, and obese individuals. Metabolism 2004: 53: 495-499.
7. Caprio S, Tamborlane WV. Metabolic impact of obesity in childhood. Endocrinol Metab Clin North Am 1999: 28: 731-747.
8. Bacha F, Saad R, Gungor N, Janosky J, Arslanian SA. Obesity, regional fat distribution, and syndrome X in obese black versus white adolescents: Race differential in diabetogenic and atherogenic risk factors. J Clin Endocrinol Metab 2003: 88: 2534-2540.
9. Brochu M, Tchernof A, Dionne IJ et al. What are the physical characteristics associated with a normal metabolic profile despite a high level of obesity in postmenopausal women? J Clin Endocrinol Metab 2001: 86: 1020-1025.
10. Cruz ML, Bergman RN, Goran MI. Unique effect of visceral fat on insulin sensitivity in obese Hispanic children with a family history of type 2 diabetes. Diabetes Care 2002: 25: 1631-1636.
11. Karelis AD, St-Pierre DH, Conus F, Rabasa-Lhoret R, Poehlman ET. Metabolic and body composition factors in subgroups of obesity: What do we know? J Clin Endocrinol Metab 2004: 89: 2569-2575.
12. Knowler WC, Barrett-C onnor E, Fowler SE et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002: 346: 393-403.
13. Tuomilehto J, Lindstrom J, Eriksson JG et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001: 344: 1343-1350.
14. Bonora E, Kiechl S, Willeit J et al. Prevalence of insulin resistance in metabolic disorders: The Bruneck Study. Diabetes 1998: 47: 1643-1649.
15. Wilson PW, Abbott RD, Castelli WP. High density lipoprotein cholesterol and mortality. The Framingham Heart Study. Arteriosclerosis 1988: 8: 737-741.
16. Sundstrom J, Lind L, Vessby B, Andren B, Aro A, Lithell H. Dyslipidemia and an unfavorable fatty acid profile predict left ventricular hypertrophy 20 years later. Circulation 2001: 103: 836-841.
17. de Ferranti SD, Gauvreau K, Ludwig DS, N eufeld EJ, Newburger JW, Rifai N. Prevalence of the metabolic syndrome in American adolescents: findings from the Third National Health and Nutrition Examination Survey. Circulation 2004: 110: 2494-2497.
18. Mc Laughlin T, Abbasi F, Cheal K, Chu J, Lamendola C, Reaven G. Use of metabolic markers to identify overweight individuals who are insulin resistant. Ann Intern Med 2003: 139: 802-809.
19. Bacha F, Saad R, Gungor N, Arslanian SA. Adiponectin in youth: relationship to visceral adiposity, insulin sensitivity, and beta-cell function. Diabetes Care 2004: 27: 547-552.
20. Arslanian SA, Lewy VD, Danadian K. Glucose intolerance in obese adolescents with polycystic ovary syndrome: Roles of insulin resistance and beta-cell dysfunction and risk of cardiovascular disease. J Clin Endocrinol Metab 2001: 86: 66-71.
21. Arslanian SA, Saad R, Lewy V, Danadian K, Janosky J. Hyperinsulinemia in African-American children: Decreased insulin clearance and increased insulin secretion and its relationship to insulin sensitivity. Diabetes 2002: 51: 3014-3019.
22. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972: 18: 499-502.
23. Caprio S. Relationship between abdominal visceral fat and metabolic risk factors in obese adolescents. Am J Human Biol 1999: 11: 259-266.
24. Gower BA, Nagy TR, Goran MI. Visceral fat, insulin sensitivity, and lipids in prepubertal children. Diabetes 1999: 48: 1515-1521.
25. Steinberger J, Moorehead C, Katch V, Rocchini AP. Relationship between insulin resistance and abnormal lipid profile in obese adolescents. J Pediatr 1995: 126: 690-695.
26. Pankow JS, Jacobs DR Jr, Steinberger J, Moran A, Sinaiko AR. Insulin resistance and cardiovascular disease risk factors in children of parents with the insulin resistance (metabolic) syndrome. Diabetes Care 2004: 27: 775-780.
27. Sinaiko AR, Jacobs DR Jr, Steinberger J et al. Insulin resistance syndrome in childhood: Associations of the euglycemic insulin clamp and fasting insulin with fatness and other risk factors. J Pediatr 2001: 139: 700-707.
28. Kahn R, Buse J, Ferrannini E, Stern M. The metabolic syndrome: Time for a critical appraisal. Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2005: 28: 2289-2304.
29. Robbins DC, Andersen L, Bowsher R et al. Report of the American Diabetes Association's Task Force on standardization of the insulin assay. Diabetes 1996: 45: 242-256.